Functional interactions between P-glycoprotein and CYP3A in drug metabolism. - Wikidata - awgldk - TriplyDB

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

http://www.wikidata.org/entity/Q34550483

about

Patient counseling about herbal-drug interactions.Using expression and genotype to predict drug response in yeast Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism.Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL Role of P-glycoprotein in statin drug interactions.Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.Pharmacogenomics of CYP3A: considerations for HIV treatment.Statin regulation of CYP3A4 and CYP3A5 expression.Human clearance prediction: shifting the paradigm.Patient variation in veterinary medicine--part II--influence of physiological variables.Experimental models for predicting drug absorption and metabolism.Interplay of drug metabolizing enzymes with cellular transporters.Everolimus and sirolimus in transplantation-related but different.Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats.Ontogeny of CYP3A and P-glycoprotein in the liver and the small intestine of the Göttingen minipig: an immunohistochemical evaluation.PXR: More Than Just a Master Xenobiotic Receptor.Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks.Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin.Should we stop dosing steroids per body surface area for nephrotics?Aloe activated P-glycoprotein and CYP 3A: a study on the serum kinetics of aloe and its interaction with cyclosporine in rats.

P2860

Q27691281-B4A50D28-20C3-4D39-BC67-D178C16611BA Q28476059-10168C12-F74D-4B48-9144-05EBD353F935 Q28484671-21F3D9A5-E463-4C34-AF92-54E6A6F14ECA Q33977228-24BE091B-3C59-4B15-9604-A8B92056141C Q34052899-70E6D0BB-5C36-43B5-9AE6-29E283C1D73A Q34313613-DBB8BD53-80EB-4F84-9862-7AD41ECCE763 Q36634221-71A05FB9-C2E6-4A36-955C-840A6C7164E7 Q36946132-A9DA6865-0284-48E7-93F5-6F373B90A75A Q37419542-16703B4B-6826-4BE2-B336-6CD4EA483A4D Q37521064-43A7AA53-0772-4508-A662-34C39F58CFA1 Q37554400-D04BBBF5-9D6C-4487-B68D-B0EFAFC7BF3E Q37810325-FEB533FC-9701-4D57-B9C1-145CB72A7AA4 Q38107970-D6767A95-29C0-444A-BFEF-B3F2C7366C8C Q38255763-7A82AE16-4546-4943-AD7E-D14952DC56C6 Q38442560-B24B51C2-DDF4-4DFD-81BD-1C19A5FE4547 Q38574619-CBC79E24-8328-4FCE-8C6C-C23295E599CF Q38984309-5F7E4770-86B6-4FBD-B701-55E9C7DA3843 Q43574589-11455E6D-2C58-4028-81E5-9C0E4CF63F2C Q45400881-85C048D0-E958-426F-B15D-CC7203AF2522 Q50117089-7CD00DFA-BB9A-41E3-94E7-DD7D536FEF05 Q50976814-8CAAA059-9617-47C6-ABAE-B20D82EB430A Q51122109-8A0F7D6E-53B9-4074-9901-7D48D5FBA325 Q52892190-8A62648A-CBDC-4E30-B34B-90EC51794A17 Q53613753-1A8BB9AD-291B-4E70-9CD5-B387F78B4A55

P2860

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

http://www.wikidata.org/entity/Q34550483

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@ast

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@en

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@nl

type

label

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@ast

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@en

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@nl

prefLabel

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@ast

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@en

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@nl

P1433

Q34550483-28AEB4EA-0337-4EB4-A9E8-620CCAF2B622

P1476

Q34550483-D9027337-AEA8-439C-8CB1-D503C4ACC0D4

P2093

Q34550483-1D0CAE87-EF90-474A-9247-885CBC3C1CB8

Q34550483-3171FB14-7B52-4D70-B1FC-35CE25DBC082

Q34550483-C86B1AB9-6252-4535-9FE2-A566264894FF

P2860

Q34550483-006ECC3C-C987-4120-AD41-F2430A53B333

Q34550483-01CC5690-4B3F-4BA1-B5F6-C50C964F959F

Q34550483-0299292E-ADD9-4698-9E80-074D0E8EDF9B

Q34550483-09891359-29FA-468A-B311-AD3E959A5165

Q34550483-11B97B5C-62BA-4E78-970D-1E4B70C92E8C

Q34550483-13AE53CC-8500-45B7-959B-316BD8AE0A23

Q34550483-160ABBA0-1A02-4068-88F0-944304302940

Q34550483-17D8934E-48F5-4595-86B0-612B403E3231

Q34550483-19B37DED-6596-4E74-8E0F-C5F755BE10B4

Q34550483-1B2DE7B9-CD57-486B-BA3D-6372D25346DD

P304

Q34550483-07FAE7C8-969F-4B2C-89F6-38EC505BCACD

P31

Q34550483-E4E483F9-5945-4500-A5E2-8EBF4FCD3054

P356

Q34550483-31F71709-BB97-45AF-9714-68E0C077D9F9

P407

Q34550483-6A7670AF-FA7C-4F7A-9A03-8A1D4E40DB81

P433

Q34550483-78B3E90C-9219-4004-ABC4-F0E9D18A6B61

P478

Q34550483-F5B35340-344B-489D-ACAA-78B111598D7A

P577

Q34550483-5305A06B-95C2-4B96-8CCF-278312CE757C

P5875

Q34550483-D518A867-D21D-4943-AF2F-537574460AB2

P698

Q34550483-C55DFA27-775A-4DFC-A3B6-66EB9EE01E41

P356

17425255.1.4.641

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

@en

P2093

Manuel Haschke

http://www.w3.org/2001/XMLSchema#string

Uwe Christians

http://www.w3.org/2001/XMLSchema#string

Volker Schmitz

http://www.w3.org/2001/XMLSchema#string

P2860

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats

The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

Genetic contribution to variable human CYP3A-mediated metabolism

Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver

Biochemistry of multidrug resistance mediated by the multidrug transporter

Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.

Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues.

Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data.

Modulation of drug metabolism in infectious and inflammatory diseases.

P304

641-654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.1.4.641

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6923529

http://www.w3.org/2001/XMLSchema#string

P698

16863430

http://www.w3.org/2001/XMLSchema#string